Ultraselective cTACE for hepatocellular carcinoma

来源 :2016第十二届亚太介入放射学大会 | 被引量 : 0次 | 上传用户:emeng
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Moderately to poorly-differentiated hepatocellular carcinoma(HCC)tissue is predominantly supplied by arterial blood.
其他文献
Objective: To evaluate the factors impacting overall survival(OS)and time to progression(TTP)in patients with unresectable HCC who receive transarterial chemoembolization(TACE).
Purpose: To evaluate efficacy and safety of sequential radiofrequency ablation(RFA)and repeatedly percutaneous ethanol injection(PEI)for treatment of patients with multiple colorectal liver metastases
Purpose To investigate the safety and feasibility of radioactive biliary stent for the therapy of locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice.
Objective: Compare the efficacy of transcatheter arterial chemoembolization combined with radiofrequency ablation for primary hepatocellular carcinoma and recurrence hepatocellular carcinoma after hep
Purpose: We previously proposed that intratumoral lactic acidosis is a target for cancer therapy.
Objective: To evaluate the value of regional arterial infusion chemotherapy and embolization in the treatment of malignant bowel obstruction(MBO).
Transcatheter arterial chemoembolization(TACE)is recommended for Barcelona Clinic Liver Cancer Stage B(BCLC-B)hepatocellular carcinoma(HCC)patients.